Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.
In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.
The company’s business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.
The company has the following service offerings:
- Capabilities in chemistry, manufacturing, and control(“CMC”)/contract development and manufacturing organisations (“CDMO”).
- CRO services include integrated discovery (“Discovery”) capabilities across biology, chemistry, drug metabolism and pharmacokinetics
As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.
As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.
Sai Life Sciences IPO – Details
| IPO Opening Date | 11 December 2024 |
| IPO Closing Date | 13 December 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 5,54,21,123 Shares Worth ₹3,042.62 Crore Fresh Issue: 1,73,04,189 Shares Worth ₹950.00 Crore Offer For Sale: 3,81,16,934 Shares Worth ₹2,092.62 Crore |
| Face Value | ₹1 per equity share |
| IPO Price | ₹522 – ₹549 per share |
| Market Lot | 27 Shares |
| Min Order | 27 Shares (1 Lot) |
| Listing At | BSE, NSE |
| Register | Kfin Technologies Limited |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Sai Life Sciences IPO – Date Schedule
| IPO Open Date | 11 November 2024 |
| IPO Close Date | 13 December 2024 |
| Basis of Allotment | 16 December 2024 |
| Initiation of Refund | 17 December 2024 |
| Credit of Shares to Demat Account | 17 December 2024 |
| IPO Listing Date | 18 December 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 13, 2024 |
Sai Life Sciences IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹1,92,699 |
| S-HNI (Min) | 14 | 378 | ₹2,07,522 |
| S-HNI (Max) | 67 | 1,809 | ₹9,93,141 |
| B-HNI (Min) | 68 | 1,836 | ₹10,07,964 |
Competitive Strengths
- As an integrated CRDMO, the company provide a complete platform for discovery, development, and manufacturing.
- CRO services include integrated discovery capabilities across biology, chemistry, and drug metabolism and pharmacokinetics.
- CDMO platform with a diverse mix of commercial and under-development molecules.
Company Promoters
- Kanumuri Ranga Raju
- Krishnam Raju Kanumuri
- Kanumuri Mytrey
- Sai Quest Syn Private Limited
- Sunflower Partners
- Lily Partners
- Marigold Partners
- Tulip Partners
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | 897.74 | 888.04 | 6.22 | 751.32 |
| 31 March 2023 | 1,245.10 | 1,228.69 | 9.98 | 699.23 |
| 31 March 2024 | 1,494.26 | 1,385.03 | 82.80 | 710.16 |
| 30 September 2024 | 693.35 | 656.09 | 28.01 | 764.49 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| P/BV | 10.18 |
| PAT Margin (%) | 5.65 |
| Pre IPO | Post IPO | |
| EPS (Rs) | 4.34 | 2.69 |
| P/E (x) | 126.42 | 203.82 |
Object Of The Issue
- Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company; and
- General corporate purposes.
Sai Life Sciences IPO Peer Comparison
| S. No. | Face Value | Company Name | PE |
| 1 | 2 | Divi’s Laboratories Limited | 103.04 |
| 2 | 1 | Suven Pharmaceuticals Limited | 109.37 |
| 3 | 10 | Syngene International Limited | 73.59 |
Sai Life Sciences IPO Promoter Holding
| Pre Issue Share Holding | 41.82% |
| Post Issue Share Holding | 35.24% |
Sai Life Sciences IPO Prospectus
Company Contact Information
| Sai Life Sciences Limited Plot No. DS-7, IKP Knowledge Park Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078 Phone: +9140 6815 6000 Email: investors@sailife.com Website: https://www.sailife.com/ |
Sai Life Sciences IPO Registrar
| Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: sailifesciences.ipo@kfintech.com Website: https://kosmic.kfintech.com/ipostatus/ |
Sai Life Sciences IPO Lead Manager(s)
| 1. IIFL Securities Limited 2. Jefferies India Private Limited 3. Kotak Mahindra Capital Company Limited 4. Morgan Stanley India Company Private Limited |
Sai Life Sciences IPO FAQs
| What is Sai Life Sciences IPO? Sai Life Sciences IPO is a main-board IPO. The issue is priced at ₹522 to ₹549 per equity share. The IPO is to be listed on BSE & NSE. |
| When Sai Life Sciences IPO will open? The IPO is to open on 11 December 2024 for QIB, NII, and Retail Investors. |
| What is Sai Life Sciences IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Sai Life Sciences IPO? You can apply Sai Life Sciences IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Sai Life Sciences IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Sai Life Sciences IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Sai Life Sciences IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Sai Life Sciences IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Sai Life Sciences IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Sai Life Sciences IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Sai Life Sciences IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Sai Life Sciences IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Sai Life Sciences IPO Size? Sai Life Sciences IPO size is ₹3,042.62 Crore. |
| What is the Sai Life Sciences IPO Price Band? Sai Life Sciences IPO Price Band is ₹522 to ₹549. |
| What is Sai Life Sciences IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 27 Shares with ₹14,823 amount while the maximum bid is 351 Shares with ₹1,92,699. |
| What is the Sai Life Sciences IPO Allotment Date? Sai Life Sciences IPO allotment date is 16 December 2024. |
| What is the Sai Life Sciences IPO Listing Date? Sai Life Sciences IPO listing date is 18 December 2024. The IPO is to be listed on BSE and NSE. |
